Promega Corporation

SignaTECT® Calcium/Calmodulin-Dependent Protein Kinase Assay System Technical Bulletin

  • Instructions for Use of Product(s)
  • V8161

Literature # TB279

The SignaTECT® Calcium/Calmodulin-Dependent Protein Kinase (CaM KII) Assay System provides an improved method to quantitate CaM KII protein kinase activity in both purified enzyme preparations and cell or tissue extracts. The SignaTECT® CaM KII System uses the unique SAM2® Biotin Capture Membrane, produced by a proprietary process that results in a high density of streptavidin on the membrane matrix.

The SignaTECT® CaM KII Assay System overcomes the problem of nonspecific substrate binding by using a biotinylated peptide that is selective for CaM KII in conjunction with the SAM2® Membrane. The high binding capacity of the SAM2® Membrane for the CaM KII biotinylated peptide substrate and low backgrounds observed with this system maximize the signal-to-noise ratio.

Printed in USA. Revised 1/13.

PDF Icon Complete Protocol PDF (551kb)

Prefer a different language?

Your country is set to Brazil. Your language is set to Português. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.